Background Dysregulated bile acid (BA) metabolism has been linked to steatosis,
inflammation, and fibrosis in nonalcoholic fatty liver disease (NAFLD). Aim To determine …

Magnetic resonance elastography-based prediction model for h... : Hepatology Magnetic
resonance elastography-based prediction model for hepatic decompensation in NAFLD: A …

Background Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM)
are independent risk factors for cardiovascular disease (CVD). Aims To examine the clinical …

The prevalence of nonalcoholic fatty liver disease (NAFLD) in the United States is 38%,
having increased by 50% within the past 3 decades. The estimated NAFLD prevalence …

Noninvasive tests (NITs) are used in all aspects of liver disease management. Their most
prominent break-through since the millennium has been in advancing early detection of liver …

Policosanol consumption has been associated with treating blood pressure and
dyslipidemia by increasing the level of high-density lipoproteins-cholesterol (HDL-C) and …

Many countries have incorporated population screening programmes for cancer, such as
colorectal and lung cancer, into their health-care systems. Cirrhosis is more prevalent than …

The rising prevalence of liver diseases related to obesity and excessive use of alcohol is
fuelling an increasing demand for accurate biomarkers aimed at community screening …

Hereditary hemochromatosis is the result of pathogenic variants in multiple genes that can
result in increased body iron stores with excess iron deposited in various organs, including …

The most current estimate suggests that in 2019, 38% of the world's adult population had
nonalcoholic fatty liver disease (NAFLD). 1 NAFLD is a complex liver disease that occurs as …